KBI also operates facilities in Durham and Research Triangle Park, NC, The Woodlands, TX, and San Diego, CA, across which the company has expanded its capabilities over the last 12 months. KBI Biopharma is continuing to increase its analytical and biophysical capabilities, by acquiring Colorado-based Elion Labs, a contract analytical organisation. The company has also acquired the US based BioTech Research Ltd, which specialises in bioinformatics for drug discovery and development. The acquisition comes following KBI's purchase of Alliance Protein Labs in 2017, and the expansion of its other facilities to add cell therapy development and manufacturing capabilities. The expansion has given KBI the most powerful analytical capacities in the industry, according to its CEO Tim Kelly.
KBI Biopharma is continuing to increase its analytical and biophysical capabilities, by acquiring Colorado-based Elion Labs, a contract analytical organisation. The company has also acquired the US based BioTech Research Ltd, which specialises in bioinformatics for drug discovery and development. The acquisition comes following KBI's purchase of Alliance Protein Labs in 2017, and the expansion of its other facilities to add cell therapy development and manufacturing capabilities. The expansion has given KBI the most powerful analytical capacities in the industry, according to its CEO Tim Kelly.